Ultrasonic Tissue Ablation System Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI3257
Ultrasonic tissue ablation system market size is expected to grow significantly from 2019 to 2025.
Growing burden of chronic diseases across the world owing to ultrasonic tissue ablation system market. As per the American Institute for Cancer Research, breast cancer is the commonly occurring cancer among women, accounting for over 2 million new cases in 2018. Furthermore, rising incidence of cardiac disease, neurological disease, gynecological disease and other chronic diseases will upsurge the demand for less- or non-invasive treatment methods. Unhealthy dietary habits, sedentary lifestyle and environmental factors will further surge chronic disease burden thereby augmenting ultrasonic tissue ablation system industry growth.
Moreover, growing investments in R&D has led to various technological advancements in healthcare industry. Growing awareness among people regarding early diagnosis and timely treatment has increased the demand for minimally invasive procedures. Numerous efforts undertaken by government and other organizations to raise awareness regarding advanced tissue ablation systems will render positive impact on the business growth. However, lack of awareness and dearth of skilled professionals in underdeveloped countries may impede ultrasonic tissue ablation system industry growth over the forecast period.
Shock wave therapy systems segment is estimated to hold significant revenue share by 2025 due to its benefits over other systems such as radiofrequency catheter ablation. Surge in demand for shock wave catheter ablation systems in cardiac diseases such as ventricular tachyarrhythmias will further spur revenue size during analysis timeline.
Cancer application segment held momentous share in ultrasonic tissue ablation system market. Growing R&D investments by key industry players in cancer treatment along with rising demand for effective and minimally invasive tissue removal procedure will augment industry growth in near future. Increasing prevalence of various types of cancer in developed as well as developing countries will augment business growth in upcoming years. Technological advancements in oncology diagnosis and treatment will favor segment growth.
Ambulatory surgical centers (ASCs) segment is anticipated to witness robust growth during the forecast period. Segment growth is attributed to advantages of these centers over hospital settings such as shorter stay, reduced risk of hospital-acquired infections, cost-effective treatment and quality care. Increasing patient preference towards ASCs along with rising technological advancements will further spur revenue size.
North America ultrasonic tissue ablation system industry will witness substantial revenue share during upcoming years. Regional growth is attributed to high healthcare expenditure and presence of well-developed infrastructure. Strong foothold of prominent industry players in the region, focusing on development of technological advanced devices will increase its adoption in the region. Increasing demand for such advanced treatment options will further foster the regional growth.
Asia Pacific ultrasonic tissue ablation system market will witness robust growth over the forecast timeframe. Presence of large patient pool in highly populated countries including China and India, susceptible to various infectious and chronic diseases will act as primary driver in regional growth. Furthermore, increasing healthcare expenditure and growing awareness about advanced surgical and non-surgical treatments will stimulate demand for ultrasonic tissue ablation system in the region.
Some of the prominent industry competitors operating in ultrasonic tissue ablation system industry include Integra LifeSciences, Misonix, Ethicon, Insightec, Alpinion Medical Systems, Chongqing Haifu Medical Technology, Mianyang Sonic Electronic, Shanghai A&S Science Technology Development and Theraclion. Industry players are focusing their efforts on developing superior ultrasonic tissue ablation system to enable minimally invasive tissue removal procedures to cater to increasing consumer demand across the globe. Innovative product launch and inorganic strategies including partnerships, merger and acquisition are undertaken by some of the leading industry players to sustain their position in the market.
Ultrasonic Tissue Ablation System Market By Type, 2014-2025 (USD Million)
- High-intensity focused ultrasonic (HIFU) ablators
- Magnetic resonance-guided focused ultrasonic (MRGFUS) ablators
- Ultrasonic surgical ablation
- Shock wave therapy systems
Ultrasonic Tissue Ablation System Market By Application, 2014-2025 (USD Million)
- Cardiac disease
- Pain management
Ultrasonic Tissue Ablation System Market By End-use, 2014-2025 (USD Million)
- Ambulatory surgical centers (ASCs)
- Specialty care units
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Alpinion Medical Systems
- Chongqing Haifu Medical Technology
- Integra LifeSciences Corporation
- Mianyang Sonic Electronic
- Shanghai A&S Science Technology Development
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability